This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Quality of Care  • Quality of Care, Other  • Genetics  • Genetic Counseling/ Testing/ Therapy  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Bridget M. Kuehn

JAMA. 2009;302(13):1405-1408.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Although the number of genetic tests available has exploded in the past decade and a half, clinicians and patients are often on their own to try to assess whether such tests might help improve care.

Tests were available for only about 100 genetic diseases in 1993, a number that soared to more than 1700 in 2008, according to GeneTests, a resource operated by the University of Washington and funded by the National Institutes of Health that includes information on genetic tests (http://www.ncbi.nlm.nih.gov/sites/GeneTests/). But governments in the United States and Europe provide limited oversight of such tests, and there is inadequate evidence on the extent to which genetic tests improve patient care.

Such concerns have led to calls for enhanced regulation of genetic tests, and recent actions suggest growing consensus among some governmental agencies, nonprofit organizations, and commercial clinical laboratories that action is needed.

The number . . . [Full Text of this Article]

GOVERNMENTS RESPOND



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?